Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study
tiragolumab、atezolizumab 和化疗治疗早期或 PD-L1 阳性晚期三阴性乳腺癌的安全性和有效性：一项 Ib 期研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105869
Kuemmel, S; Jung, K H; Andrade, L; Assad-Suzuki, D; de la Cruz Merino, L; Freitas-Junior, R; Hegg, R; Huang, C-S; Martin, H; Schneeweiss, A; Dieterich, M; Nguyen Duc, A; Feng, Y; Meng, R; Swat, A; Seiller, A; Bermejo, B; Hamilton, E P
